Details for New Drug Application (NDA): 200477
✉ Email this page to a colleague
The generic ingredient in RISEDRONATE SODIUM is risedronate sodium. There are nineteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the risedronate sodium profile page.
Summary for 200477
Tradename: | RISEDRONATE SODIUM |
Applicant: | Norvium Bioscience |
Ingredient: | risedronate sodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 200477
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Nov 30, 2015 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
Approval Date: | Nov 30, 2015 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 35MG | ||||
Approval Date: | Nov 30, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription